News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Reshaped Pfizer Inc. (PFE) Plans to Fine-Tune Research Spending


10/8/2013 7:22:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nearly three years after a cost-cutting drive that stunned many in the drugs industry, Pfizer Inc's head of research Mikael Dolsten says his scientists are delivering more for less. The ability of the biggest U.S. drugmaker to slash research spending by a fifth without reducing the flow of new drugs has boosted returns on invested capital, been applauded by Wall Street and not gone unnoticed at rivals. Last week, Merck & Co Inc followed a similar path with a plan to cut costs and scrap 8,500 jobs.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES